|
|
|
|
|
|
|
|
"In 2004, the US Preventive Services Task Force (amongst other countries/guidelines) recommended against routine ovarian cancer screening [102]. None of the more recent findings overide this guideline. We must await the results of the two large-scale trials. Whether the results are positive or not, these trials will yield vital data to guide the next steps in biomarker research and subsequent guidelines for practice."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.